Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle-Reference-Cited by-同舟云学术

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle

Published:2023-11-30 Issue:11 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Glujovsky Demián¹,Pesce Romina²,Miguens Mariana¹,Sueldo Carlos³,Ciapponi Agustín⁴

Affiliation:

1. Reproductive Medicine; CEGYR (Centro de Estudios en Genética y Reproducción); Buenos Aires Argentina

2. Reproductive Medicine; Hospital Italiano de Buenos Aires; Buenos Aires Argentina

3. Reproductive Medicine; CEGYR (Centro de Estudios en Ginecologia y Reproducción); Buenos Aires Argentina

4. Argentine Cochrane Centre; Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET); Buenos Aires Argentina

Publisher

Wiley

Subject

Pharmacology (medical)

Reference72 articles.

1. Begueria R Garcia D Vassena R Rodriguez A Medroxyprogesterone acetate versus ganirelix in oocyte donation cycles stimulated using GnRH antagonist protocol triggered with GnRH agonist: a randomized controlled trial (RCT) Human Reproduction 2018 i108

2. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial;Begueria;Human Reproduction,2019

3. The use of dydrogesterone to prevent lh peak in random-start ovarian stimulation for fertility preservation;Braham;Fertility and Sterility,2020

4. Dydrogesterone for prevent LH surge yields similar outcomes to ganirelix in a shared oocyte donor cycle with subsequent frozen-thawed embryo transfer: comparison of donors and recipients;Cambiaghi;Fertility and Sterility. Conference: 75th Scientific Congress of the American Society for Reproductive Medicine, October 12-16, 2019, Philadelphia, Pennsylania,2019

5. Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial;Chen;Frontiers in Endocrinology,2019